152 related articles for article (PubMed ID: 1666824)
21. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
Ledford RM; Collett MS; Pevear DC
Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
[TBL] [Abstract][Full Text] [Related]
22. 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
Kelley JL; Linn JA; Krochmal MP; Selway JW
J Med Chem; 1988 Oct; 31(10):2001-4. PubMed ID: 2845083
[TBL] [Abstract][Full Text] [Related]
23. Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds.
Gruenberger M; Pevear D; Diana GD; Kuechler E; Blaas D
J Gen Virol; 1991 Feb; 72 ( Pt 2)():431-3. PubMed ID: 1847178
[TBL] [Abstract][Full Text] [Related]
24. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
Badger J; Minor I; Kremer MJ; Oliveira MA; Smith TJ; Griffith JP; Guerin DM; Krishnaswamy S; Luo M; Rossmann MG
Proc Natl Acad Sci U S A; 1988 May; 85(10):3304-8. PubMed ID: 2835768
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
Desideri N; Mastromarino P; Conti C
Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
[TBL] [Abstract][Full Text] [Related]
26. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
Rossmann MG
Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses.
Kaiser L; Crump CE; Hayden FG
Antiviral Res; 2000 Sep; 47(3):215-20. PubMed ID: 10974374
[TBL] [Abstract][Full Text] [Related]
29. Antirhinoviral activity of heterocyclic analogs of Win 54954.
Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
[TBL] [Abstract][Full Text] [Related]
30. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
[TBL] [Abstract][Full Text] [Related]
31. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
[TBL] [Abstract][Full Text] [Related]
32. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
[TBL] [Abstract][Full Text] [Related]
33. Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders.
Morley A; Tomkinson N; Cook A; MacDonald C; Weaver R; King S; Jenkinson L; Unitt J; McCrae C; Phillips T
Bioorg Med Chem Lett; 2011 Oct; 21(20):6031-5. PubMed ID: 21907579
[TBL] [Abstract][Full Text] [Related]
34. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.
Basta HA; Ashraf S; Sgro JY; Bochkov YA; Gern JE; Palmenberg AC
Virology; 2014 Jan; 448():82-90. PubMed ID: 24314639
[TBL] [Abstract][Full Text] [Related]
35. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions.
Al-Nakib W; Tyrrell DA
Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156
[TBL] [Abstract][Full Text] [Related]
36. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
[TBL] [Abstract][Full Text] [Related]
37. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
38. Computer simulation study of the binding of an antiviral agent to a sensitive and a resistant human rhinovirus.
Lybrand TP; McCammon JA
J Comput Aided Mol Des; 1989 Jan; 2(4):259-66. PubMed ID: 2541225
[TBL] [Abstract][Full Text] [Related]
39. Virus-ligand interactions: identification and characterization of ligand binding by NMR spectroscopy.
Benie AJ; Moser R; Bäuml E; Blaas D; Peters T
J Am Chem Soc; 2003 Jan; 125(1):14-5. PubMed ID: 12515488
[TBL] [Abstract][Full Text] [Related]
40. Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication.
Da Costa L; Scheers E; Coluccia A; Casulli A; Roche M; Di Giorgio C; Neyts J; Terme T; Cirilli R; La Regina G; Silvestri R; Mirabelli C; Vanelle P
J Med Chem; 2018 Sep; 61(18):8402-8416. PubMed ID: 30153009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
